TAVI

When Aortic Stenosis Becomes a Treatment Decision

Being told that your aortic valve is severely narrowed can feel unsettling, especially if you have already been living with shortness of breath, chest pressure, dizziness, or a gradual loss of energy. Many patients describe the same experience: activities that once felt ordinary, such as walking uphill, climbing stairs, traveling, or carrying groceries, begin to feel increasingly difficult. For some, the diagnosis comes after a fainting episode or a heart murmur found during a routine examination. For others, it is discovered while being assessed for another medical condition.

Aortic stenosis is not simply a sign of aging. It is a structural heart valve disease that can place significant strain on the heart. When the valve between the heart’s main pumping chamber and the aorta becomes stiff or narrowed, the heart must work harder to push blood forward. Over time, this can lead to worsening symptoms, reduced heart function, heart failure, and other serious complications.

For many years, replacing the aortic valve required open-heart surgery. Today, selected patients can be treated with TAVI, also known in the United States as TAVR, a catheter-based procedure that replaces the diseased valve without the need for traditional open-heart surgery in most cases. This option can be especially important for older adults and for patients whose overall health makes conventional surgery higher risk.

Choosing where to have TAVI is a significant decision. International patients often want to understand not only whether the procedure is appropriate, but also how it is planned, how risks are managed, how long recovery may take, and how care will be coordinated far from home. At Acibadem, TAVI is evaluated and performed within a structured cardiovascular program, with cardiologists, cardiovascular surgeons, imaging specialists, anesthesiology teams, intensive care physicians, and international patient coordinators working together to guide each stage of care.

What TAVI Is

TAVI stands for transcatheter aortic valve implantation. The procedure is also commonly called TAVR, or transcatheter aortic valve replacement. Both terms describe the same principle: a replacement aortic valve is delivered to the heart through a thin tube called a catheter and implanted inside the patient’s narrowed native valve.

The aortic valve sits between the left ventricle, the heart’s main pumping chamber, and the aorta, the large artery that carries oxygen-rich blood to the body. In aortic stenosis, this valve becomes narrowed, often because calcium builds up on the valve leaflets over time. Instead of opening freely, the valve becomes stiff and restricted. This limits blood flow and increases pressure inside the heart.

During TAVI, the replacement valve is compressed onto a catheter and advanced through a blood vessel, most often from the femoral artery in the groin. Once the valve is positioned precisely inside the diseased aortic valve, it is expanded. The new valve pushes the narrowed valve leaflets aside and begins functioning immediately, allowing blood to flow more easily from the heart to the rest of the body.

TAVI is considered minimally invasive because it usually avoids opening the chest and does not typically require stopping the heart. Many patients are treated under conscious sedation or general anesthesia, depending on their clinical situation and the team’s assessment. The approach is individualized, with careful planning based on imaging, vascular anatomy, valve measurements, medical history, and the patient’s overall risk profile.

It is important to understand that TAVI is not a “minor” procedure. It is an advanced structural heart intervention that requires detailed pre-procedure evaluation and a highly coordinated team. Its less invasive nature can reduce the physical burden of treatment for selected patients, but safety depends on accurate diagnosis, careful patient selection, precise imaging, and experienced clinical judgment.

Who May Need TAVI

TAVI may be considered for patients with severe aortic stenosis, particularly when symptoms are present or when heart testing shows that the valve disease is placing significant strain on the heart. The decision is not based on symptoms alone. Some patients reduce their activity gradually without realizing how limited they have become. Others have few symptoms but show concerning findings on echocardiography or other tests.

Common symptoms that may lead to evaluation for TAVI include shortness of breath during exertion, chest pain or pressure, fatigue, dizziness, fainting, palpitations, swelling in the legs, and reduced ability to exercise. Some patients develop episodes of heart failure, such as breathlessness when lying down, sudden nighttime shortness of breath, or fluid retention. In advanced cases, symptoms may occur with minimal activity or even at rest.

Diagnosis usually begins with a clinical examination and a heart ultrasound called an echocardiogram. This test measures how narrow the valve is, how well the heart is pumping, and how much pressure is building across the valve. Additional tests may include electrocardiography, blood tests, chest imaging, coronary angiography, cardiac computed tomography, and assessments of kidney function, lung health, frailty, and other medical conditions.

A detailed CT scan is particularly important in planning TAVI. It helps measure the aortic valve opening, the size of the valve ring, the shape of the aortic root, the location of the coronary arteries, and the condition of the arteries that may be used for catheter access. These measurements help the team select an appropriate valve size and determine the safest route to the heart.

TAVI is often considered for patients who are older, medically complex, or at increased risk for open-heart surgery. This may include patients with previous cardiac surgery, lung disease, kidney disease, frailty, reduced heart function, or other conditions that increase surgical risk. In some situations, TAVI may also be an option for patients at lower surgical risk, depending on the valve anatomy, age, life expectancy, patient preference, and current guideline-based recommendations.

The most appropriate treatment is determined through a heart team evaluation. This typically includes interventional cardiologists and cardiovascular surgeons, supported by cardiac imaging specialists, anesthesiologists, and other specialists as needed. The goal is not simply to decide whether TAVI can be done, but whether it is the best option for the individual patient compared with surgical valve replacement, medical management, or other approaches.

Conditions and Indications TAVI Addresses

The primary indication for TAVI is severe aortic valve stenosis, most often caused by age-related calcification of the aortic valve. As calcium deposits accumulate, the valve becomes rigid and cannot open normally. This is common in older adults, but the timing and severity vary from person to person.

TAVI may also be considered in selected patients with a narrowed bicuspid aortic valve, a valve that developed with two leaflets instead of the usual three. Bicuspid anatomy can be more complex because the valve may be asymmetric, heavily calcified, or associated with enlargement of the aorta. Careful imaging and specialist review are essential before deciding whether TAVI is suitable.

Another situation is valve-in-valve TAVI, in which a transcatheter valve is implanted inside a previously placed surgical bioprosthetic valve that has deteriorated over time. This may be an option for selected patients who have already undergone valve surgery in the past and now face renewed valve narrowing or leakage. The decision depends on the size and type of the prior valve, coronary anatomy, and the risk of future procedures.

In some cases, patients may have mixed aortic valve disease, meaning both narrowing and leakage are present. TAVI is primarily designed to treat stenosis, but it may be considered when stenosis is the dominant problem and the anatomy is appropriate. Pure aortic regurgitation, where the valve leaks but is not significantly narrowed or calcified, requires separate assessment and is not always suitable for standard TAVI techniques.

TAVI may be especially relevant when severe aortic stenosis is contributing to heart failure symptoms, reduced exercise tolerance, or recurrent hospitalizations. It may also be evaluated before other major medical treatments or surgeries, because untreated severe valve disease can increase the risk of procedures unrelated to the heart.

How TAVI Is Performed

TAVI begins well before the procedure day. The first step is confirmation that the aortic stenosis is severe and that valve replacement is medically appropriate. Patients are assessed with echocardiography, CT imaging, blood tests, rhythm evaluation, and, when indicated, coronary angiography to check for blockages in the heart arteries. The team also reviews medications, allergies, prior procedures, kidney function, neurological history, and bleeding risk.

For international patients, pre-arrival review may begin with medical records, imaging reports, echocardiography results, angiography images, laboratory tests, and physician summaries. Once the patient arrives, additional testing may be performed to confirm findings and finalize the treatment plan. This is important because TAVI depends on exact anatomical measurements and current clinical status.

Before the procedure, the care team explains the planned access route, anesthesia approach, expected monitoring, possible risks, and recovery process. Blood-thinning medications may need adjustment. Patients are usually asked not to eat or drink for a period before the procedure. If there are dental infections, active infections elsewhere in the body, or unstable medical issues, these may need to be addressed before valve implantation.

Most TAVI procedures use the transfemoral approach, meaning the catheter is inserted through an artery in the groin. This approach is preferred when the leg and pelvic arteries are large enough and healthy enough to allow safe passage of the delivery system. If the transfemoral route is not suitable, alternative access routes may be considered, depending on the patient’s anatomy and the experience of the heart team.

On the day of TAVI, the patient is brought to a specialized cardiac catheterization laboratory or hybrid operating environment equipped for structural heart procedures. Monitoring includes heart rhythm, blood pressure, oxygen levels, and imaging guidance. The procedure may be performed under conscious sedation, where the patient is relaxed and comfortable but not fully asleep, or under general anesthesia. The choice depends on clinical factors, procedural complexity, and team preference.

Using imaging guidance, the physician places small tubes into the blood vessels, usually in the groin. A temporary pacing wire may be placed to control the heart rhythm briefly during key parts of the implantation. The replacement valve is advanced through the catheter toward the heart. Fluoroscopy, a type of real-time X-ray imaging, and echocardiography help guide positioning.

In some patients, the narrowed valve may be gently expanded with a balloon before the new valve is implanted. In others, the new valve is positioned and expanded directly. Once released, the replacement valve anchors within the diseased valve. The team immediately checks valve function, blood flow, pressure measurements, and whether there is any leakage around the valve. If needed, additional adjustments may be performed.

The types of technology used in TAVI are designed to improve accuracy, planning, and safety. High-resolution CT imaging helps map the valve and blood vessels before treatment. Echocardiography evaluates valve function and heart performance. Angiographic imaging provides live guidance during the procedure. Advanced monitoring helps the team respond quickly to rhythm changes, blood pressure shifts, or access-site concerns. The purpose of this technology is not complexity for its own sake; it is to match the treatment to the patient’s anatomy and reduce avoidable uncertainty.

The procedure itself often takes one to two hours, although the full time in the procedure area may be longer because of preparation and post-procedure checks. More complex anatomy, additional coronary procedures, vascular challenges, or medical instability can lengthen the process. After TAVI, patients are taken to a recovery area, intensive care unit, or monitored cardiac unit depending on their condition and the hospital’s protocol.

Early recovery focuses on heart rhythm monitoring, blood pressure control, access-site observation, kidney function, mobility, and neurological checks. Some patients need a pacemaker after TAVI if the heart’s electrical system is affected by the new valve. This risk varies based on anatomy, pre-existing conduction abnormalities, and the type and position of the valve.

Many patients are encouraged to sit, stand, and walk relatively soon after the procedure, once the access site is stable and the care team approves. Hospital stay is often shorter than after open-heart surgery, but the exact length depends on the patient’s age, frailty, heart rhythm, kidney function, recovery pace, and whether additional treatment is needed. Discharge planning includes medication instructions, wound care, activity guidance, warning signs, and follow-up appointments.

Why Acting Early Matters

Severe aortic stenosis can remain stable for a time, but once symptoms develop, the condition may progress in a way that significantly affects survival and quality of life if left untreated. The narrowed valve forces the heart to pump against high resistance. Over time, the heart muscle may thicken, stiffen, weaken, or become unable to meet the body’s needs.

Delaying evaluation can increase the risk of heart failure, fainting, abnormal heart rhythms, pulmonary hypertension, and reduced functional capacity. Some patients adapt by doing less, which can mask the seriousness of the condition. A person may believe they are “just getting older” when, in fact, the valve disease is limiting blood flow.

Early assessment does not always mean immediate intervention. Some patients need close monitoring until the stenosis reaches a threshold for treatment. However, once severe symptomatic aortic stenosis is confirmed, timely valve replacement is usually recommended unless there are reasons treatment would not be appropriate. The earlier the heart team understands the full picture, the better it can plan treatment before a crisis occurs.

For international patients, timing also matters because travel requires coordination. Medical records may need translation or review, imaging may need repeating, and medications may need adjustment before the procedure. Planning ahead allows a safer and more organized experience than waiting until symptoms become urgent.

Benefits of TAVI

For appropriately selected patients, TAVI can offer important clinical and practical advantages compared with living with untreated severe aortic stenosis or undergoing more invasive surgery.

Benefit	What It Means for You
Improved blood flow through the aortic valve	The new valve can relieve the obstruction, allowing the heart to pump blood more effectively to the body.
Less invasive approach	Most procedures are performed through an artery in the groin, usually without opening the chest or using traditional open-heart surgery.
Shorter early recovery for many patients	Selected patients may walk soon after the procedure and leave the hospital sooner than is typical after surgical valve replacement.
Symptom relief	Many patients experience less shortness of breath, improved stamina, and better ability to perform daily activities after recovery.
Option for higher-risk surgical patients	TAVI may make valve replacement possible for patients who face increased risk with open surgery because of age, frailty, or other medical conditions.
Team-based decision-making	Evaluation by cardiology, cardiac surgery, imaging, anesthesia, and other specialists helps determine whether TAVI is the right approach for your anatomy and health status.

Recovery Timeline After TAVI

Recovery varies by age, baseline health, heart function, access route, and whether any rhythm or vascular issues occur, but many patients follow a general pattern like the one below.

Time Period	What Patients Can Expect
Day 1	Close monitoring of heart rhythm, blood pressure, access site, kidney function, and neurological status. Some patients begin sitting up and walking with assistance.
First Week	Gradual increase in walking and daily activity. Mild groin tenderness or bruising may occur. Medication instructions and follow-up plans are reviewed before travel or discharge.
First Month	Energy and breathing often improve progressively. Patients usually avoid heavy lifting and strenuous exertion until cleared by their physician. Follow-up testing may include echocardiography and rhythm assessment.
Longer Term	Ongoing cardiology follow-up is important to monitor valve function, medications, blood pressure, and overall heart health. Cardiac rehabilitation may be recommended for selected patients.

Factors That Influence Outcomes

A good TAVI result depends on much more than placing a new valve. Outcomes are influenced by patient selection, valve anatomy, vascular access, heart function, rhythm status, other medical conditions, procedural planning, and post-procedure care.

One of the most important factors is whether symptoms are truly caused by aortic stenosis. Some patients also have lung disease, coronary artery disease, anemia, arrhythmias, or deconditioning, all of which can contribute to shortness of breath or fatigue. Treating the valve may help significantly, but additional conditions may also need management for the best functional recovery.

The anatomy of the aortic valve and surrounding structures is central to planning. Heavy calcium, bicuspid valve shape, small valve size, low coronary arteries, enlarged aorta, or narrow peripheral arteries can affect procedural strategy. Detailed imaging helps anticipate these issues before the patient enters the procedure room.

Heart rhythm is another key consideration. Some patients already have conduction disease, such as bundle branch block, before TAVI. Because the replacement valve sits close to the heart’s electrical pathways, a pacemaker may be needed in some cases after the procedure. Careful monitoring helps identify rhythm problems early.

Kidney function also matters, particularly because CT scans and angiographic imaging may require contrast dye. In patients with chronic kidney disease, the team may adjust imaging protocols, hydration strategies, medications, and monitoring to reduce risk. Similarly, patients with a history of stroke, bleeding, or vascular disease may require tailored planning.

Medication management after TAVI is individualized. Many patients need antiplatelet or anticoagulant therapy, especially if they have atrial fibrillation, coronary stents, or other clotting risks. The right regimen balances protection against clotting with the risk of bleeding. Patients should not stop or change these medications without medical guidance.

Long-term results also depend on the patient’s overall cardiovascular care. Blood pressure control, diabetes management, cholesterol treatment, smoking cessation, appropriate exercise, dental hygiene, and follow-up echocardiography all play a role. TAVI treats the narrowed valve, but it does not replace the need for ongoing heart care.

Why International Patients Choose Acibadem for TAVI

For patients traveling from the United States, Europe, the Middle East, Africa, and other regions, the decision to undergo TAVI abroad involves both medical and practical considerations. Patients want clarity: Is the diagnosis correct? Is TAVI appropriate? Who will review the case? How will the procedure be planned? What happens if something unexpected occurs? How will follow-up be coordinated after returning home?

At Acibadem, TAVI care is organized around a multidisciplinary cardiovascular model. Cases are reviewed by experienced physicians from relevant specialties, including interventional cardiology, cardiovascular surgery, cardiac imaging, anesthesiology, intensive care, and other disciplines when needed. This team-based approach is especially important for complex valve disease, where the best treatment may depend on subtle differences in anatomy and surgical risk.

Acibadem hospitals are JCI-accredited, reflecting internationally recognized standards for patient safety, quality processes, infection control, and clinical governance. For a procedure such as TAVI, these systems matter. The patient journey includes structured pre-procedure evaluation, procedural safety protocols, monitored recovery, medication reconciliation, and discharge planning.

Advanced cardiovascular imaging and interventional environments support the planning and performance of TAVI. CT-based anatomical assessment, echocardiography, angiographic guidance, hemodynamic monitoring, and intensive care resources help the heart team make informed decisions before, during, and after the procedure. The goal is to align the technical plan with the patient’s anatomy and clinical needs.

International patients also require a different level of coordination. Acibadem International provides support in more than 20 languages, assisting with medical record transfer, appointment planning, interpretation, hospital admission, discharge coordination, and communication with clinical teams. For many patients and families, this reduces the confusion that can occur when navigating a complex heart procedure in another country.

Personalized treatment planning is central to the evaluation. Some patients who request TAVI may be better served by surgical valve replacement. Others may need coronary treatment before or during the same care pathway. Some may require optimization of heart failure, rhythm control, kidney function, or infection risk before the valve procedure. A responsible program does not treat TAVI as a one-size-fits-all intervention; it determines whether the procedure is appropriate and how to perform it as safely as possible.

For patients seeking a second opinion, Acibadem can review available echocardiograms, CT scans, angiography images, operative reports, and physician notes. When imaging is incomplete or outdated, repeat testing may be recommended. The purpose of a second opinion is not only to confirm eligibility, but also to explain options clearly so patients can make decisions with their families and physicians.

Travel planning after TAVI is also individualized. Some patients may be able to return home relatively soon after discharge, while others should remain nearby for additional monitoring. The decision depends on recovery, rhythm stability, access-site healing, medication needs, and flight duration. Patients receive guidance on activity, wound care, warning symptoms, medications, and follow-up with their local cardiologist.

Moving Forward With Confidence and Clarity

TAVI has changed the treatment landscape for severe aortic stenosis, particularly for patients who may not be ideal candidates for open-heart surgery. It offers a less invasive way to replace a narrowed aortic valve, but it still requires careful evaluation, precise imaging, expert procedural planning, and attentive recovery care.

If you or a loved one has been diagnosed with severe aortic stenosis, the next step is to understand whether the condition has reached the point where valve replacement is needed and which approach is most appropriate. A structured TAVI assessment can help clarify the diagnosis, estimate procedural risk, identify anatomical considerations, and compare treatment options.

Acibadem’s cardiovascular teams and international patient services can support you through this process, from record review and second opinion requests to in-person evaluation and treatment planning. For patients traveling for care, the aim is to provide clear communication, coordinated medical decision-making, and a care plan shaped around the individual patient rather than the procedure alone.

This information is general and is not a substitute for professional medical advice. Diagnosis and treatment decisions should always be made with a qualified physician who can assess your individual medical condition.